Elshad Hasanov

8PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patients.

|May 18, 2026
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and Resistance.

|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.

|Oct 12, 2023
Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.

Nathaniel R Wilson, Yusuf Acikgoz, Elshad Hasanov

|Aug 01, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail

|Oct 18, 2022
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma.

Ahmed O Kaseb, Yinghui Guan, Betul Gok Yavuz

Pageof 2

Frequent Collaborators

2 joint publications

Omar Alhalabi

2 joint publications

Nizar M Tannir

2 joint publications

Eric Jonasch

1 joint publications

Yulei Wang